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Abstract
Background: Global health investment has reduced HIV mortality and transmission. However, little is known of
patient-reported outcomes alongside ART rollout. This study aimed to measure wellbeing using patient-reported
outcome measures (PROMS) among outpatients at PEPFAR-funded facilities.
Methods: In a multicentre 2 country cross-sectional study, adults attending 12 facilities in Kenya and Uganda gave
self-reported data on quality of life (physical and mental wellbeing dimensions), functional and a measure of
multidimensional problems (physical, psychological, social and spiritual).
Results: Among the 1,337 participants, multidimensional problems were more common in psychological, spiritual and
social domains than in physical. In multivariable analysis using GEE to adjust for facility effect, the mental health
subscale of quality of life was lower for people with limited functional status (B = −5.27, 95% CI −5.99, 1. −4.56 p <
0.001) and higher for wealthier people (B = 0.91, 95% CI 0.48, 1.33, p < 0.001). The physical health subscale of quality of
life was lower for those with limited functional status (B = −8.58, 95% CI −9.46 to −7.70, p < 0.001) and those who had a
caregiver present (B = −1.97, 95% CI −3.72 to −0.23, p = 0.027), higher for wealthier people (B = 1.14, 95% CI 0.65, 1.64,
p < 0.001), and positively associated with CD4 count (B = 1.61, 95% CI 1.08–2.14, p < 0.001). Multidimensional problems
were more burdensome for people with limited functional status (B = −2.06, 95% CI −2.46 to −1.66, p < 0.001), and less
burdensome with more education (B = 0.63, 95% CI 0.25–1.00, p = 0.001) or ART use (B = 0.94, 95% CI 0.34–1.53,
p = 0.002).
Conclusions: Multidimensional problems are highly prevalent, and worse with declining function. Importantly, ART use
does not appear to be protective for self-reported physical and mental dimensions of quality of life. Assessment and
management of self-reported wellbeing must form part of HIV care and treatment services to ensure maximum benefit
from ART investment.
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Background
High prevalence and associated burden of physical and
psychological problems have been reported among HIV
outpatients with access to antiretroviral therapy (ART)
in high income countries [1-4]. Within the generalised
epidemic of sub-Saharan Africa, evidence of patient-
reported problems since the rollout of ART has mainly
related to later stages of HIV disease [5,6]. The World
Health Organisation (WHO) definition of health is
‘complete physical, mental and social well-being’, [7] and
WHO guidance also identifies the need for the assess-
ment and management of physical, psychological, social
and spiritual problems from the point of HIV diagnosis
and alongside treatment [8].
Although global evidence suggests that patients bear a
high burden of problems from the point of HIV diagnosis
[9], clinical skills and research since the advent of ART
have focused mainly on outcomes of viral suppression and
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delaying mortality, and arguably have lost patient-
centredness [10-12]. Patient reported outcome mea-
sures (PROMS) have been identified as essential tools to
promote quality and equity in healthcare [13]. An evalu-
ation of the effect of PEPFAR (President’s Emergency
Plan for AIDS Relief ) funding in its target countries has
established that there has been a decrease in HIV-
related deaths [14] and a reduction in the number of
HIV-positive births [15]. However, there has been a lack
of evaluative evidence of the management of patients’
health from their own perspective; therefore it is un-
clear whether optimal benefit is being achieved from
treatment investment.
This paper aims to measure patient wellbeing using
PROMS among HIV outpatients at PEPFAR-funded facil-
ities, and to determine associations with patient problems.
Methods
Study design
As part of a mixed-methods Public Health Evaluation
(PHE) of the President’s Emergency Plan for AIDS Relief
(PEPFAR) Care and Support programme, a multi-centre,
longitudinal quantitative study was conducted of care re-
ceived and patient-health outcomes over three months
in Kenya and Uganda (full protocol available [16]). This
paper presents the cross-sectional analysis of results at
baseline.
Study design and setting
During the longitudinal observational cohort of the PHE,
consecutive HIV-infected outpatients were recruited from
12 PEFAR-funded care facilities in Kenya and Uganda.
Kenya and Uganda are PEPFAR focus countries with
generalised epidemics.
Ethics
Ethical approval to undertake the study was received
from the Uganda National Council for Science and
Technology (UNCST, Ref SS 1964), the Kenyan Medical
Research Institute (Ref KEMRI/RES/7/3/1) and the
College Research Ethics Committee at King’s College
London (Ref CREC/06/07-140). Subsequent tool changes
following initial piloting were also approved.
Procedure for recruitment, data collection and analysis
Adult outpatients who were aware of their HIV diagno-
sis and able to give informed consent (either written or
thumb print depending on literacy level) were invited
into the study. Consecutive patients were approached in
outpatient waiting areas in the order of their attendance,
and trained researchers conducted consenting and data
collection. All questionnaires were forward/back trans-
lated into local languages, and all questions read aloud.
Respondents gave a verbal response to each item, and
the study researcher recorded the response. This re-
duced any potential bias, as limited literacy could lead to
a mix of self-completion and researcher-completion. Pa-
tients gave a self-report on demographic data as follows;
age (coded 18–29, 30–39, 40–63), gender (male/female),
country of recruitment (Kenya/Uganda), number of de-
pendents (coded as 0–1, 2–3, 4+), time to travel to the
facility (coded as an hour or less/more than an hour),
and ART use (yes/no). Socioeconomic status was mea-
sured following the methodology used in the Demo-
graphic and Health Surveys [17], using variables including
house construction, possession of items, fuel supply etc.
The entire sample of 1,337 people was included. ART use
and CD4 count were the only variables not self-reported
(these were extracted from file).
Finally three self-report scales were completed, each
having been previously validated in sub-Saharan African
populations. These were: the Medical Outcome Scale -
HIV (MOS-HIV), which is a 35-item quality of life scale
in Uganda and widely used in Africa [18,19] consists of
two subscales of physical and mental health (each sub-
scale analysed as quintiles) and is sensitive to treatment
effects [20]; the APCA African Palliative Outcome Scale
(POS) [21] has seven patient-reported multidimensional
items that reflects the WHO definition of palliative care,
(i.e. it measures physical, psychological, social and spirit-
ual problems among those with incurable life-limiting
illness, analysed as quintiles, and referred to as the
POS); the ECOG Performance Status, which is a single
item rating of functional status ranging from 0 = fully ac-
tive to 5 = dead. (coded 0/1/2+) [22]. Participants were
paid $5 for travel expenses.
Data management and entry
Data were collected in a private space away from other
patients, and questionnaires carried only a unique study
participant identifier. Questionnaires were stored in a
locked cabinet. Data were entered into a pre-designed
EpiData v3.1 database (Odense Denmark: EpiData As-
sociation; 2000–2008). Errors were identified using
consistency checks and double-entry validation, and
followed-up by manual checking of questionnaires.
Stata v10 (Texas: Stata Corp LP; 2007) was used to
undertake descriptive analysis and tests of association.
MOS-HIV item scores were converted into continuous
summary scores for mental and physical health (0–100)
[23]. The scores for the seven patient-completed items
of the APCA African POS (pain, symptoms, worry,
peace/spiritual wellbeing, sharing feelings, feeling life
worthwhile, help and advice) were summed to create a
total patient POS score. Additionally, all individual POS
item scores were coded into ternary variables (0/1 = low
problem, 2/3 = moderate problem, 4/5 = severe prob-
lem) presented by facility. The wealth quintile variable
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was created following the methods of the Demographic
Health Surveys [17,24], using factor analysis with prin-
cipal components analysis to create a continuous vari-
able. This variable was then divided into quintiles. Age
was grouped into categories: 18–29, 30–39, 40–49, 50–
59 and 60–70. CD4 was categorised 0–100, 101–200,
201–350 and 351 to maximum. Demographic character-
istics and outcomes were described by facility (facilities
were labelled A-M to retain anonymity). The asso-
ciation between continuous outcomes (mental health,
physical health and total POS score) and facility was
tested using analysis of variance.
The main outcomes were quality of life using two sub-
scales of physical and mental health score from the
MOS-HIV, and the POS [23].
T-tests and analysis of variance were used to identify
demographic and clinical characteristics associated with
the three outcomes in bivariate analysis. The individual
POS item scores were included as co-variates for quality
of life mental and physical health subscales but not for
total POS scores, because they were components of it
and so association was inevitable. Multilevel fixed-effects
linear regression was used to analyse whether scores
were associated with personal characteristics, adjusting
for facility clustering. All variables associated with an
outcome in bivariate analysis were taken forward into
the multivariate model. CD4 count was not used in a
model if the presence of a CD4 test result on file was as-
sociated with the outcome. Population-averaged models
were fitted using generalised estimating equations (GEE)
to adjust for the effect of facility. The three outcomes
were mental health subscale score, physical health sub-
scale score, and total patient POS score.
Results
Sample description
Table 1 shows the demographic characteristics of the sam-
ple by facility. One participant did not give demographic
data, leaving a total sample in the analysis of 1336 partici-
pants, an average of 111.4 per facility (range 102–125). In
total 68.3% were female (57.7%–78.5% by facility), and the
mean age was 34.8 (32.1–38.8 by facility).
Descriptive outcomes
For the entire sample of n = 1336, mean quality of life
mental health subscale score was 46.2 (95% CIs 45.7–46.8)
(Table 2). By facility, the range was from 40.3 to 49.7 and
the difference between facilities was statistically significant
(F = 10.46, p < 0.001). Quality of life physical health sub-
scale mean score was 44.9 for the entire sample (95% CIs
44.2–45.5), ranging from 37.9 to 49.5 by facility, which
was statistically significant (F = 12.61, p < 0.001). The mean
total POS score was 20.8 (95% CIs 20.5–21.1) and ranged
from 19.1 to 22.6 by facility, which was also statistically
significant (F = 6.94, p < 0.001).
Review of the POS scores shows that items for which
the greatest proportion of respondents fell into the “se-
vere problem” category were ‘need for help/advice’
(51.6% severe) and ‘difficulty sharing feelings’ (43.5% se-
vere) and feeling at peace (21.1%). In seven facilities,
more than half of participants had severe problems with
obtaining help/advice. For both these items there was
only one facility where fewer than 10% had severe prob-
lems – facility G. Psychological, spiritual and social
problems were more common than physical problems.
Bivariate analysis
At 5% significance, quality of life mental health subscale
was associated with wealth quintile, education, having a
caregiver present, functional status and having a CD4
count on file, while physical health was associated with
age group, wealth quintile, education, ART use, CD4
count result, being newly diagnosed, having a carer
present and functional status (Table 3). Poorer and less
educated people, with limited functional status, those
with a carer present and those lacking a CD4 count on
file were more likely to have lower (worse) mental health
subscale score. Older, poorer and less educated people
taking ART, with a long-standing HIV diagnosis, those
having a carer present and those with limited function
were more likely to have lower (worse) physical health.
Both the MOS-HIV outcomes were associated with CD4
count result, but since having a CD4 count was associ-
ated with mental health, the CD4 test result could not
be considered as a covariate of mental health because of
sampling bias. Total patient POS score was associated
with wealth quintile, education, ART use, functional sta-
tus and having a CD4 count on file. POS multidimen-
sional problems were more common among people who
were poorer, less educated, with lower function, who
were not taking ART or did not have a CD4 count on
file.
All seven patient-completed POS items were associ-
ated with both the MOS-HIV outcomes. Mental and
physical health quality of life subscale scores were lower
(worse) for participants with moderate or severe pain,
symptoms and worry, and for those who reported low
scores for finding peace or for obtaining help and advice.
Participants with moderate problems finding life worth-
while had slightly lower physical and mental health
scores than those with severe difficulty. Participants with
severe difficulty sharing feelings had better MOS-HIV
scores than those with low or moderate problems.
Multivariable analysis
Using GEE (Table 4), mental health quality of life
subscale was lower (worse) for people with limited
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Table 1 Demographic characteristics of sample by facility N = 1336
Facility
A B C D E F G H J K L M
N 109 111 120 120 125 111 107 105 112 107 102 107
Gender (% female) 68.8 74.8 65.8 72.5 70.4 57.7 78.5 64.8 60.7 61.7 71.6 72.0
Mean age (range) 33.0 (18–69) 38.6 (21–63) 33.9 (18–59) 33.5 (18–58) 34.8 (19–58) 33.7 (18–60) 37.8 (18–70) 38.8 (21–66) 32.1 (18–53) 33.7 (22–67) 34.9 (18–55) 33.0 (19–61)
Education None 5.6 2.7 1.7 5.0 2.4 0.9 25.2 14.3 4.5 3.7 6.9 8.4
Began primary 69.4 54.1 55.8 50.0 40.8 54.1 53.3 57.1 35.7 58.0 37.3 53.3
Began
secondary
22.2 38.7 30.8 37.5 46.4 37.8 20.6 25.7 48.2 26.2 39.2 27.1
Diploma 1.9 3.6 10.8 7.5 7.2 6.3 0.9 1.0 6.3 10.3 13.7 8.4
Degree 0.9 0.9 0.8 0 3.2 0.9 0 1.9 5.4 1.9 2.9 2.8
Wealth quintile Poorest 39.5 2.7 5.0 1.7 15.2 37.3 80.4 43.8 2.7 3.7 5.9 19.6
Middle poor 32.1 27.0 25.8 3.3 14.4 24.6 6.5 47.6 4.5 10.3 8.8 26.2
Middle 19.3 33.3 15.8 15.0 33.6 19.1 10.3 4.8 19.6 23.4 15.7 27.1
Middle
wealthy
8.3 19.8 21.7 28.3 21.6 12.7 1.9 2.9 42.9 30.8 30.4 17.8
Wealthiest 0.9 17.1 31.7 51.7 15.2 6.4 0.9 1.0 30.4 31.8 39.2 9.4
Has a CD4 test result on
file (%)
88.1 91.0 85.8 99.2 90.4 89.2 100.0 41.0 50.4 46.7 90.2 33.6
CD4 count (%) N 96 101 103 116 113 99 107 43 57 50 92 36
0–100 16.7 2.0 29.1 27.6 13.3 15.2 9.4 9.3 12.3 16.0 20.7 8.3
101–200 15.6 19.8 19.4 19.8 17.7 24.2 30.8 7.0 10.5 20.0 16.3 13.9
201–350 28.1 37.6 20.4 21.6 29.2 21.2 36.5 30.2 22.8 36.0 22.8 36.1
351+ 39.6 40.6 31.1 31.0 39.8 39.4 23.4 53.5 54.4 28.0 40.2 41.7
Newly diagnosed (%) 36.7 2.7 63.3 54.2 19.2 35.1 0 17.1 70.8 25.2 34.3 29.0
Taking ART (%) 66.7 67.6 8.3 40.0 56.5 31.5 91.6 36.2 8.9 14.0 38.2 60.7
Has a carer (%) 8.3 9.0 15.8 12.5 14.4 10.8 98.1 3.8 13.4 3.7 19.7 9.4
ECOG 0 56.0 74.8 80.0 75.0 58.4 71.2 20.6 79.1 82.1 51.4 43.1 23.4
1 33.9 22.5 19.2 20.8 34.4 20.7 37.4 19.1 9.8 43.9 45.1 63.6
2 9.2 2.7 0.8 4.2 6.4 7.2 38.3 0 4.5 2.8 8.8 8.4
3 or 4 0.9 0 0 0 0.8 0.9 3.7 1.9 3.6 1.9 2.9 4.7
Mean number of care
components received during
study (SD)
15.5 (6.0) 11.5 (6.2) 8.4 (4.9) 15.8 (6.7) 10.1 (5.8) 9.9 (5.1) 23.9 (4.2) 22.0 (6.3) 13.0 (6.4) 13.8 (3.9) 20.1 (4.1) 16.0 (4.3)
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Table 2 Patient outcome scores by facility, MOS-HIV and POS N = 1336
A B C D E F G H J K L M All
Mean mental health score (SD) 47.0 (10.1) 49.7 (8.2) 47.5 (10.2) 48.4 (9.5) 49.5 (9.7) 46.4 (8.6) 42.6 (7.3) 40.3 (8.9) 43.9 (10.6) 47.0 (9.4) 47.7 (9.3) 43.9 (9.6) 46.2 (9.7)
Mean physical health score (SD) 43.1 (12.8) 49.5 (9.2) 47.4 (11.6) 46.7 (11.8) 47.1 (9.6) 42.6 (11.2) 37.9 (9.7) 38.5 (12.3) 49.0 (11.4) 45.8 (10.9) 46.7 (12.5) 42.8 (10.7) 44.9 (11.7)
POS: Mean total patient score (SD) 22.6 (5.5) 22.1 (4.9) 20.9 (5.5) 22.4 (4.9) 20.6 (5.1) 22.0 (5.8) 21.3 (4.9) 19.2 (4.4) 19.7 (4.3) 20.0 (5.5) 19.6 (4.5) 19.1 (5.3) 20.8 (5.2)
Pain (%) Moderate 47.7 43.2 35.8 31.7 53.6 47.8 71.0 68.6 33.9 38.3 51.0 59.8 48.2
Severe 8.3 6.3 4.2 8.3 14.4 6.3 15.9 18.1 2.7 14.0 2.9 15.0 9.7
Symptoms Moderate 36.7 26.1 40.8 20.8 33.6 35.1 58.9 50.4 35.7 48.6 36.3 36.5 38.1
Severe 4.6 1.8 0.8 3.3 4.0 1.8 9.4 4.8 0.9 9.4 2.0 8.4 4.2
Worry Moderate 22.9 20.7 30.0 29.2 30.4 32.4 57.0 61.0 42.9 16.8 42.2 35.5 34.9
Severe 17.4 9.0 10.0 11.7 9.6 9.9 15.0 16.2 13.4 24.3 6.9 14.0 13.0
Difficulty sharing feelings Moderate 31.2 27.0 24.2 19.2 21.6 21.6 31.8 32.4 32.1 27.1 65.7 33.6 30.2
Severe 47.7 49.6 66.7 60.8 55.2 45.1 6.5 15.2 61.6 40.2 33.3 31.8 43.5
Difficulty finding life worthwhile Moderate 15.6 14.4 20.0 12.5 16.8 13.5 23.4 59.1 31.3 20.6 36.3 43.0 25.1
Severe 3.7 23.4 10.0 9.2 12.8 21.6 0.9 17.1 11.6 6.5 7.8 22.4 12.3
Lack of peace Moderate 28.4 21.6 30.8 30.0 28.0 22.5 42.1 62.9 48.2 21.5 49.0 45.8 35.6
Severe 11.0 13.5 15.8 13.3 26.4 13.5 33.6 23.8 23.2 33.6 11.8 34.6 21.1
Need for help/advice Moderate 22.9 22.5 14.2 17.5 27.2 47.8 48.6 31.4 14.3 21.5 32.4 34.6 27.7
Severe 36.7 59.5 69.2 52.5 51.2 36.9 10.3 41.9 77.7 71.0 65.7 44.9 51.6
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Table 3 Bivariate analysis for each outcome MOS-HIV physical health, MOS-HIV mental health, and POS N = 1336
Mental health score Physical health score Total patient POS score
Mean (95% CIs) Test result Mean (95% CIs) Test result Mean (95% CIs) Test result
Gender Male 46.6 (45.7–47.5) t = 0.94, p = 0.347 44.1 (42.9–45.2) t = −1.64, p = 0.101 21.0 (20.5–21.6) F = 1.15, p = 0.284
Female 46.1 (45.4–46.7) 45.2 (44.5–46.0) 20.7 (20.4–21.0)
Age group 18–29 46.3 (45.2–47.3) F = 1.11, p = 0.348 45.9 (44.7–47.1) F = 2.64, p = 0.032 20.7 (20.2–21.2) F = 1.71, p = 0.146
30–39 45.9 (45.1–46.7) 45.1 (44.2–46.1) 20.5 (20.1–20.9)
40–49 46.4 (45.3–47.5) 43.3 (41.8–44.7) 21.3 (20.7–21.9)
50–59 48.2 (46.4–50.1) 43.7 (41.1–46.2) 21.6 (20.6–22.5)
60–70 44.5 (40.3–48.7) 42.0 (39.1–44.9) 22.1 (19.0–25.2)
Wealth quintile Poorest 43.1 (42.1–44.2) F = 14.41, p < 0.001 40.2 (38.8041.5) F = 25.26, p < 0.001 20.8 (20.1–21.4) F = 2.48, p = 0.042
Middle poor 45.3 (44.1–46.6) 42.9 (41.5–44.4) 20.4 (19.8–21.0)
Middle 46.4 (45.2–47.5) 45.2 (43.8–46.5) 20.6 (19.9–21.2)
Middle wealthy 47.7 (46.6–48.8) 47.6 (46.3–48.8) 20.6 (20.0–21.2)
Wealthiest 48.8 (47.6–50.0) 48.7 (47.3–50.1) 21.7 (21.1–22.3)
Education None 43.6 (41.6–45.5) F = 4.65, p = 0.003 41.0 (38.5–43.5) F = 5.65, p < 0.001 19.6 (18.5–20.7) F = 5.31, p = 0.001
Began primary 46.1 (45.4–46.9) 44.4 (43.5–45.2) 20.7 (20.3–21.0)
Began secondary 46.3 (45.4–47.2) 45.9 (44.9–46.9) 20.9 (20.4–21.4)
Diploma+ 48.7 (47.1–50.3) 46.7 (44.2–49.1) 22.4 (21.4–23.3)
ART Yes 46.4 (45.7–47.2) t = −0.62, p = 0.536 44.0 (44.7–46.4) t = 2.34, p = 0.020 21.3 (20.9–21.8) F = 10.59, p = 0.001
No 46.1 (45.4–46.8) 45.5 (43.1–44.9) 20.4 (20.0–20.8)
Newly diagnosed Yes 46.4 (45.5–47.3) t = −0.46, p = 0.648 46.3 (45.1–47.4) t = −3.09, p = 0.002 20.8 (20.4–21.3) F = 0.01, p = 0.936
No 46.2 (45.5–46.8) 44.2 (43.4–44.9) 20.8 (20.5–21.1)
Has a carer Yes 43.5 (42.4–44.7) t = 4.82, p < 0.001 39.9 (38.3–41.4) t = 7.48, p < 0.001 21.2 (20.5–21.8) F = 1.50, p = 0.220
No 46.8 (46.3–47.4) 46.0 (45.3–46.6) 20.7 (20.4–21.0)
Functional status 0 49.0 (48.4–49.7) F = 72.73, p < 0.001 49.7 (49.0–50.4) F = 197.63, p < 0.001 21.8 (21.5–22.2) F = 32.01, p < 0.001
1 43.1 (42.2–43.9) 39.8 (38.8–40.8) 19.6 (19.1–20.1)
2 39.4 (38.0–40.9) 31.7 (30.0–33.5) 18.1 (17.1–19.1)
3/4 35.7 (33.2–38.2) 24.3 (20.9–27.7) 17.7 (15.7–19.7)
Has a CD4 test result on file Yes 46.9 (46.3–47.4) t = −4.16, p < 0.001 45.1 (44.4–45.8) t = −1.41, p = 0.159 21.0 (20.7–21.3) F = 7.10, p = 0.008
No 44.3 (43.2–45.4) 44.1 (42.7–45.4) 20.1 (19.6–20.7)
CD4 count 0–100 49.0 (48.2–49.9) F = 8.33, p < 0.001 44.5 (43.3–45.6) F = 25.41, p < 0.001 20.7 (19.9–21.5) F = 0.38, p = 0.769
101–200 50.4 (49.8–51.1) 47.6 (46.8–48.4) 21.2 (20.4–21.9)
201–350 51.4 (50.8–51.9) 49.8 (49.2–50.4) 21.2 (20.6–21.8)
351-max 51.3 (50.9–51.8) 50.5 (50.0–51.0) 21.0 (20.5–21.5)
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Table 3 Bivariate analysis for each outcome MOS-HIV physical health, MOS-HIV mental health, and POS N = 1336 (Continued)
Pain Low 50.1 (49.4–50.8) F = 99.40, p < 0.001 51.3 (50.5–52.1) F = 217.20, p < 0.001
Moderate 44.2 (43.5–44.9) 41.4 (40.5–42.2)
Severe 39.8 (38.0–41.6) 34.4 (32.6–36.3)
Symptoms Low 48.8 (48.2–49.5) F = 78.98, p < 0.001 49.2 (48.4–49.9) F = 165.51, p < 0.001
Moderate 43.2 (42.4–43.9) 39.7 (38.8–40.7)
Severe 38.6 (36.0–41.2) 32.3 (29.5–35.1)
Worry Low 49.9 (49.2–50.5) F = 136.9, p < 0.0016 47.9 (47.1–48.6) F = 54.81, p < 0.001
Moderate 43.5 (42.7–44.3) 42.4 (41.3–43.5)
Severe 39.1 (37.6–40.7) 39.6 (37.9–41.3)
Sharing feelings Low 45.4 (44.4–46.4) F = 6.10, p = 0.002 41.9 (40.7–43.2) F = 41.51, p < 0.001
Moderate 45.5 (44.6–46.4) 42.8 (41.6–43.9)
Severe 47.3 (46.5–48.1) 48.1 (47.2–48.9)
Finds life worthwhile Low 48.1 (47.5–48.8) F = 49.89, p < 0.001 46.0 (45.2–46.8) F = 12.06, p < 0.001
Moderate 42.3 (41.3–43.2) 42.3 (41.1–43.5)
Severe 44.6 (43.0–46.2) 44.3 (42.4–46.1)
Peace Low 51.0 (50.3–51.7) F = 169.79, p < 0.001 48.1 (47.2–49.0) F = 49.65, p < 0.001
Moderate 43.9 (43.1–44.7) 43.6 (42.5–44.6)
Severe 40.3 (39.2–41.4) 40.3 (38.9–41.7)
Help and advice Low 48.6 (47.5–49.7) F = 10.27, p < 0.001 45.3 (43.9–46.7) F = 5.30, p = 0.005
Moderate 45.8 (44.8–46.7) 43.2 (42.0–44.4)
Severe 45.6 (44.8–46.3) 45.6 (44.7–46.4)
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functional status (B = −5.27 95% CI −5.99, −4.56) and
slightly higher (better) for wealthier people (B = 0.91,
95% CI 0.48 to 1.33, p < 0.001). Physical health quality
of life subscale was lower (worse) for those with limited
functional status (B = −8.58, 95% CI −9.46 to −7.670,
p < 0.001) and for those who had a caregiver present
(B = −1.97, 95% CI −3.72 to −0.23, p = 0.027), higher
(better) for wealthier people (B = 1.14, 95% CI 0.65 to
1.64, p < 0.001), and positively associated with CD4
count (B = 1.61, 95% CI 1.08–2.14, p < 0.001). Multi-
dimensional POS problems were more burdensome
for people with limited functional status (B = −2.06, 95%
CI −2.46 to −1.66, p < 0.001), less burdensome for those
with more education (B = 0.63, 95% CI 0.25–1.00, p =
0.001) or those using ART (B = 0.94, 95% CI 0.34–1.53,
p = 0.002).
Discussion and conclusion
Our data reveal severe problems for patients’ access to
help and advice and to their ability to share feelings.
Generally, social and spiritual problems were self-
reported as worse than physical problems. This suggests
that the concept of health as defined by the WHO needs
greater clinical attention. In the context of a generalised
epidemic and limited resources, implying a high patient
load per health professional, time may be limited for help
and advice. Routine assessment of multi-dimensional
problems and referral to non-medical/nursing staff may
be a feasible approach to achieving wellbeing. Holistic as-
sessment and care are required, especially as we found
that those with worse physical and mental health reported
poor wellbeing in terms of being at peace (a measure of
spiritual wellbeing [25]), and gaining help and advice. It is
also important to note that within the POS, the greatest
proportion of respondents who identified severe problems
were for the items on accessing help and advice, sharing
feelings, and being at peace. Inequalities persist in terms
of those with less education having a worse POS score
(multidimensional problems) and worse mental health for
the less wealthy, demonstrating that within the global
health debate we must recognise inequalities within low
income countries. The quantitative POS data are sup-
ported by qualitative data from these facilities, which iden-
tified the multidimensional problems of outpatients in line
with the WHO definition of palliative care, i.e. problems
in the physical, psychological, social and spiritual domains
[26]. The data also demonstrate a higher burden of phys-
ical and mental ill-health, and multidimensional problems,
with poorer functional status. Socioeconomic status and
education are closely associated with each other, therefore
only one or the other is associated with outcomes in
multivariate models. We note from previous analysis of
people newly diagnosed with HIV in East Africa that help/
advice is closely associated with education (contributing
significantly to the total POS score) [27], which may ex-
plain our finding of an association between education ra-
ther than poverty and total POS score.
An analysis of ART-naïve HIV outpatients in Uganda
found very similar MOS-HIV mean physical subscale
score (46.18 vs 44.9 in our sample) and mental subscale
score (46.19 vs 46.2) [28]. The MOS-HIV subscale mean
scores in our sample are worse compared to recent data
from Belgium (mean physical health subscale in Belgium
55.6 vs 44.9 in our sample, mean mental health 52.0 in
Belgium vs 46.2 in our sample) [29] although a greater
proportion of the sample in Belgium were male (78.9%
vs 31.7% and on ART (92.0% vs 43.4%).
There are several limitations to our data. Firstly, the
use of self-report data may be less robust in regions with
limited literacy and less experience of questionnaire use.
We reduced this potential bias by only using question-
naires validated on local populations, and by researchers
administering all questionnaires. Second, clinical data
(i.e. ART use and CD4 count) were reliant on availability
on file, and therefore we were unable to analyse variables
where this was not routinely collected and recorded. We
have reported separate analyses of factors associated
with the presence of a CD4 count on file [30]. Third, the
Table 4 Generalised estimating equations for each model MOS-HIV physical health, MOS-HIV mental health, and POS
N = 1336
Mental health score Physical health score POS score
Coefficient (95% CIs) p Coefficient (95% CIs) p Coefficient (95% CIs) p
Age −0.05 (−1.08,0.01) 0.079
Wealth quintile 0.91 (0.48,1.33) <0.001 1.14 (0.65,1.64) <0.001 0.16 (−0.08,0.39) 0.192
Functional status −5.27 (−5.99,-4.56) <0.001 −8.58 (−9.46,-7.70) <0.001 −2.06 (−2.46,-1.66) <0.001
Newly diagnosed −0.08 (−1.47,1.30) 0.907
Has a carer −1.13 (−2.63,0.37) 0.141 −1.97 (−3.72,-0.23) 0.027
CD4 count 1.61 (1.08,2.14) <0.001
Education 0.07 (−0.60,0.74) 0.838 0.11 (−0.69,0.92) 0.783 0.63 (0.25,1.00) 0.001
Using ART 1.00 (−0.29,2.23) 0.128 0.94 (0.34,1.53) 0.002
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data are cross sectional and therefore we can determine
associations not causality.
It is notable that our findings confirm previous
European evidence that ART use is not associated with
physical or mental health [3]. We do not suggest that
ART is not effective in improving outcomes, but that
people on treatment continue to have multidimensional
problems that require support across domains of need
to achieve optimal health. We recently completed two
trails of an intervention [31] in response to the findings
in the present paper that these problems persist and are
burdensome alongside treatment.
From these data we conclude that all patients require
holistic assessment and care irrespective of ART use or
functional status, but that those with worse function or
with a lower socioeconomic status require additional
support beyond the medical management of their HIV
disease.
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